A carregar...
Encapsulation of temozolomide in a tumor-targeting nanocomplex enhances anti-cancer efficacy and reduces toxicity in a mouse model of glioblastoma
Although temozolomide (TMZ) is the current first-line chemotherapy for glioblastoma multiforme (GBM), most patients either do not respond or ultimately fail TMZ treatment. Both intrinsic tumor resistance and limited access of TMZ to brain tumors as a result of the blood-brain barrier (BBB) contribut...
Na minha lista:
Publicado no: | Cancer Lett |
---|---|
Main Authors: | , , , , , |
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
2015
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4600672/ https://ncbi.nlm.nih.gov/pubmed/26325605 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.canlet.2015.08.022 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|